FLSM
STRO icon

Frazier Life Sciences Management’s Sutro Biopharma STRO Stock Holding History

Frazier Life Sciences Management’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-78,000
Closed -$2.71M – 57
2023
Q3 		$2.71M Hold
78,000
– – 0.18% 46
2023
Q2 		$3.63M Sell
78,000
-99,648
-56% -$4.96M 0.22% 44
2023
Q1 		$8.21M Hold
177,648
– – 0.59% 32
2022
Q4 		$14.4M Hold
177,648
– – 0.89% 22
2022
Q3 		$9.86M Hold
177,648
– – 0.76% 29
2022
Q2 		$9.26M Hold
177,648
– – 0.87% 30
2022
Q1 		$14.6M Buy
+177,648
New +$16.9M 1.24% 29

Other funds holding STRO

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return